STORIES
Susan Emery
“I’ve always loved horses and now I run an equestrian centre on a beautiful property just outside of Sydney.”
John Newsom
“Staying happy and keeping your sense of humour is vital in dealing with cancer.”
Karen Fallah
“I was a busy mother of two, with my daughter doing her HSC at the time.”
Ross McBride
"I’m a potter and have always had a keen passion for art. I kept this up over the years as an art teacher."
Neryl Benson
"I was shocked to learn that I had stage three bowel cancer, and shortly afterwards two thirds of my bowel was removed."
Dan Kent
“Like most men I only ever visited the doctor if I was half dead from the flu or needed stitches.”
Jan Mumford
“My children were only 4, 2 and 3 months old at that time and my husband and I did our best to cope.”
Charles Titmuss
“There are after effects of cancer that stay with patients every day, both physical and emotional.”
Pamela Todd
“For me, the important things in life are people.”
Trevor Beggs
“Trevor loved music and was skilled at delivering a one-liner that would have his family doubled over in laughter.”TESTIMONIALS
“AGITG's success is reflected in the trials results that its members have published over the years, in high quality journals including the New England Journal of Medicine. ”
“The AGITG is staffed a network of researchers who facilitate an energetic culture of multidisciplinary clinical research in gastro-intestinal cancer, to aid the timely delivery of new anti-cancer agents into clinical use.”
“I have only the highest regard for the professionalism of the staff working for the AGITG and the processes they use to ensure the robustness of each of their clinical trials.”
“In late 2007 Cancer Voices Australia decided to enter into a collaboration with the AGITG. We particularly noted AGITG’s reputation both internationally and in Australia for excellence in research and its readiness to engage with cancer survivors and carers in the formulation, execution and ultimate translation of research projects into effective clinical practice.”
“I believe that the trials they have already conducted have made significant contributions to the management of cancer.”
“The AGITG has an international reputation for research excellence and is the Australasian trials organisation with the ability to make inroads into the disease.”
“AGITG is well placed to lead clinical research in pancreatic cancer as the group has direct experience with large multi-site national and international clinical trials and have recruited in excess of 500 patients to their trials to date”
The GI CANCER Institute raises funds for the Australasian Gastro Intestinal Trials Group (AGITG).
Dr Ian Olver MD PhD CEO Cancer Council Australia
“The AGITG is staffed a network of researchers who facilitate an energetic culture of multidisciplinary clinical research in gastro-intestinal cancer, to aid the timely delivery of new anti-cancer agents into clinical use.”
Dr Andrew Penman, CEO Cancer Council NSW
“I have only the highest regard for the professionalism of the staff working for the AGITG and the processes they use to ensure the robustness of each of their clinical trials.”
Dr Rob Padbury, MMBS PhD FRACS President, ANZHPBA
“In late 2007 Cancer Voices Australia decided to enter into a collaboration with the AGITG. We particularly noted AGITG’s reputation both internationally and in Australia for excellence in research and its readiness to engage with cancer survivors and carers in the formulation, execution and ultimate translation of research projects into effective clinical practice.”
John Newsom, Chair Cancer Voices Australia.
“I believe that the trials they have already conducted have made significant contributions to the management of cancer.”
A/Prof Bogda Koczwara - Chairman, Medical Oncology Group of Australia
“The AGITG has an international reputation for research excellence and is the Australasian trials organisation with the ability to make inroads into the disease.”
Prof Bruce Mann President, Clinical Oncology Society of Australia (COSA).
“AGITG is well placed to lead clinical research in pancreatic cancer as the group has direct experience with large multi-site national and international clinical trials and have recruited in excess of 500 patients to their trials to date”